Cardiac apoptosis: From organ failure to allograft rejection

Journal of Cellular and Molecular Medicine

Volumn 5, Issue 2, 2001, Pages 143-152

  Hinescu, M E ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Apoptosis; Heart failure; Heart transplantation; Ischemia; Myocytes

Indexed keywords

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CARDIOMYOPATHY; CELL DEATH; CONGESTIVE HEART FAILURE; GRAFT REJECTION; HEART MUSCLE; HUMAN; PATHOLOGY; REPERFUSION INJURY; REVIEW;

ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; CELL DEATH; GRAFT REJECTION; HEART FAILURE, CONGESTIVE; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; REPERFUSION INJURY;

EID: 0035527324     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2001.tb00147.x     Document Type: Article

References (61)

1. Toner P.G., Kamel H.M.H., Cameron S., Organelle pathology in cell injury. In: McGee J.O'D., Isaacson P.C., Wright N.A., Oxford Textbook of Pathology, vol. 1, Oxford University Press, Oxford, pp.157-181, 1992
2. Sander C., Genomic medicine and the future of health care, Science, 287:1977-1978, 2000
3. DenHoff M.J.B., den Eijnde S.M., Viragh S., Moorman A.F., Programmed cell death in the developing heart, Circ. Res., 45:603-620, 2000
4. Renies T., Wheatley D.N., Cytoplasmic vacuolation, adaptation and cell death: A view on new perspectives and features, Biol. Cell., 91:485-498, 1999
5. Zakeri Z., The study of cell death by the use of cellular and developmental models, In: Lockshin R.A., Zakeri Z., Tilly J.L. (Eds.), When Cell Die, Wiley-Liss, pp. 97-129, 1998
6. Majno G., Joris L, Apoptosis, oncosis, and necrosis. An overview of cell death, Am. J. Pathol., 146:3-15, 1995
7. James T.N., Apoptosis in congenital heart disease, Coronary Art. Dis., 8:599-616, 1997
8. James T.N., Normal and abnormal consequences of apoptosis in the human heart, Annii. Rev. Physiol., 60:309-325, 1998
9. Yaoita II., Ogawa K., Maehara K., Maruyama Y., Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction, Cardiovasc. Res., 45:630-641, 2000
10. Poelmann R.E., Molin D., Wisse L.J., Gittenberger de Groot A.C., Apoptosis in cardiac development, Cell Tissue Res., 301:43-52, 2000
11. Narula J., Kolodgie F.D., Virmani R., Apoptosis and cardiomyopathy, Curr. Opin. Cardiol., 15:183188,2000
12. James T.N., Apoptosis in cardiac disease, Am. J. Med., 107:606-620, 1999
13. Sabbah H.N., Sharov V.G., Apoptosis in heart failure, Prog. Cardiovasc. Dis., 40:549-562, 1998
14. Sabbah H.N., Sharov V.G., Goldstein S., Programmed cell death in the progression of heart failure, Ann. Med.,30(Suppl.l ): 33-38, 1998
15. Fadeel B., Orrenius S., Zhviotovsky B., Apoptosis in human disease: A new skin for the old ceremony?, Biochem. Biophys. Res. Commun., 266:699-717,1999
16. Anversa P., Leri A., Beltrami C.A., Guerra S., Kajstura J., Myocyte death and growth in the failing heart, Lab. Invest., 78:767-786, 1998
17. Sabbah H.N., Apoptotic cell death in heart failure, Cardiovasc. Res., 45:704-712, 2000
18. Thomas F., Wu J., Thomas J.M., Apoptosis and organ transplantation, Curr. Opin. Organ Transplant., 5:35-41, 2000
19. Taylor D.O., Immunosuppressive therapies after heart transplantation: best, better, and beyond, Curr. Opin. Cardiol., 15:108-114, 2000
20. Knosalla C, Hummel M., Muller J., Grauhan O., Ewert R., Hetzer R., Diagnosis of heart graft rejection, Curr. Opin. Organ Transplant, 5:118-152, 2000
21. James T.N., Alperin J.B., Apoptotic myocardial degeneration in thrombotic thrombocytopenic purpura, Apoptosis, 2:384-394, 1997
22. James T.N., Long reflections on the QT interval: The sixth annual Gordon K. Moe Lecture, J. Cardiovasc. Electrophysiol., 7:738-759, 1996
23. James T.N., Martin E.S., Willis P.W. Ill, Lohr T.O., Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with the absence of the AV node, sinus node, and internodal pathways, Circulation, 93:1424-1438, 1996
24. Walsh K., Isner J.M., Apoptosis in inflammatoryfibroproliferative disorders of the vessel wall, Cardiovasc. Res., 45:756-765, 2000
25. Lopez-Farre A., Rodroguez-Feo J.A., de Miguel L.S., Rico L., Casado S., Role of the nitric oxide in the control of apoptosis in the microvasculature, Int. J. Biochem. Cell Biol., 30:1095-1106, 1998
26. Kockx M.M., Knaapen W.M., The role of apoptosis in vascular disease, J Pathol., 190:267-280, 2000
27. McCarthy N.J., Bennett M.R., The regulation of vascular smooth muscle cell apoptosis, Cardiovasc. Res., 45:747-755, 2000
28. Mayr M., Xu Q.,Smooth muscle cell apoptosis in atherosclerosis, Exp. Gerontol., 36:969-987, 2001
29. Kockx M.M., Herman A.G., Apoptosis in atherosclerosis: beneficial or detrimental?, Cardiovasc. Res., 45:736-746, 2000
30. Yue T-L., E.H. Ohlstein, R.R. Ruffolo Jr., Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases, Curr. Opin. Chem. Biol., 3:474-480, 1999
31. Bishopric N.H., Andreka P., Slepak T., Webster K.A., Molecular mechanisms of apoptosis in cardiac myocyte, Citrr. Opin. Pharmacol., 1:141-150, 2001
32. Saraste A., Pulkki K., Morphological and bichemical hallmarks of apoptosis, Cardiovasc. Res., 45:528-537, 2000
33. Dispersyn G.D., Borgers M, Flameng W., Apoptosis in chronic hibernating myocardium: sleeping to death?, Cardiovasc. Res., 45:696-703, 2000
34. Haunstetter A., Izumo S., Apoptosis. basic mechanisms and implications for cardiovascular disease, Circ. Res., 82:1111-1129, 1998
35. Buja M., Entman M.L., Modes of myocardial cell injury and cell death in ischémie heart disease, Circulation, 98:1355-1357, 1998
36. Anversa P., Myocyte death in the pathological heart, Circ. Res., 86:121-124, 2000
37. Cotter T.G, Martin S.J. (eds.), Techniques in Apoptosis. A User's Guide, Portland Press Ltd, London, 1996
38. Boraschi D., Bossu P., Cossarizza A., Apoptosis. A Laboratory Manual of Experimental Methods, Cooperation Group in Immunology GCI, Rome, 1998
39. Kashima K., Yokoyama S., Daa T., Nakayama I., Iwaki T., Immunohistochemical :study on tissue transglutaminase and cooper-zinc Superoxide dismutase in human myocardium: its relevance to apoptosis detected by the nick end labelling method, Virchows Arch., 430:333-338, 1997
40. Olivetti G, Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., Quinain E., Di Loreto C., Beltrami C.A., Krajewski S., Reed J.C. Anversa P., Apoptosis in the failing human heart, N. Engl. J. Med., 336:1131-1141, 1997
41. Narula J., Raider N., Virmani R., DiSalvo T.G, Kolodgie F.D., Hajjar R.J., Schmidt U., Semigran M.J., Dec GW., Khaw B.A., Apoptosis in myocytes in end-stage heart failure, N. Engl. J. Med., 335:1182-1189,1996
42. Veinot J.P., Gattinger D.A., Fliss H., Early apoptosis in human myocardial infarcts, Hum. Patlwl., 28:485-492, 1997
43. Gottlieb R.A., Burleson K.O., Babior B.M., Engler R.L., Reperfusion injury induces apoptosis in rabbit cardiomyocytes, J. Clin. Invest., 94:16211628, 1994
44. Suzuki H., Wildhirt S.M., Dudek R.R., Narayan K.S., Bailey A.H., Bing R.J., Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages, Tissue & Cell, 28:89-97, 1996
45. Stadelmann C., Lassmann H., Detection of apoptosis in tissue sections, Cell Tissue Res., 301:19-31,2000
46. Ohno M., Takemura G., Ohno A., Misao J., Hayakawa Y., Minatoguki S., Fujiwara T, Fujiwara H., "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation, Circulation, 98:1422-1430, 1998
47. Tea B.S., Dam T.V., Moreau P., Hamet P., deBlois D., Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity, Hypertension, 34:229-235, 1999
48. Bushell A., Wood KJ., Permanent survival of organ transplants without immunosuppression: Experimental approaches and possibilities for tolerance induction in clinical transplantation, Exp. Rev. Mol. Med., (http://www-ermm.cbcu.cam-ac.uk): 1-31,1999
49. Laufer G., Berlakowich G.A., Kocher A., Multiorgan transplantation: heart-kidney, liver-kidney, Curr. Opin. Organ Transplant., 5:306-311,2000
50. Cho C.S., Fechner J.H., Knechtle S.J., T-cell depletion as a means of achieving tolerance, Curr. Opin. Organ Transplant., 5:96-102, 2000
51. Kishimoto K., Dong V.M., Sayegh M.H., The role of costimulatory molecules as targets of new immunosuppressives in transplantation, Curr. Opin. Urology., 10:57-62, 2000
52. Kung L., Gourishankar S., Halloran P.F., Molecular pharmacology of immuno-suppressive agents in relation to their clinical use, Curr. Opin. Organ Transplant., 5:268-275, 2000
53. Gauthier P., Helderman J.H., Cyclosporine avoidance, J.Am. Soc. Nephrol, 11:1933-1936,2000
54. Haunstetter A., Izumo S., Future perspectives and potential implications of cardiac myocyte apoptosis, Cardiovasc. Res., 45:795-801, 2000
55. MacLellan W.R., Schneider M.D., Death by design. Programmed cell death in cardiovascular biology and disease, Circ. Res., 81:137-144, 1997
56. Kajstura J., Cigola E., Malhotra A., Li P., Cheng W., Meggs L.G., Anversa P., Angiotensin II induces apoptosis of adult ventricular myocytes in vitro, J. Moll. Cell. Cardiol., 29:589-870, 1997
57. Voicu V.A., Hinescu M.E., Marculescu Z., Alexandrescu R., Perieteanu M., Jiquidi M., Angiotensin-converting enzyme inhibitors attenuate hypoxia-induced apoptosis in myocardial cells, Naunyn-Schiniedeberg's Arch. Plmrmacol. 358(suppl 2):R643 (abst.), 1998
58. Feuerstein G.Z., Young P.R., Apoptosis in cardiac diseases: stress- and mitogen activated signaling pathways, Cardiovasc. Res., 45:560-569, 2000
59. Mullauer L., Gruber P., Sebinger D., Buch J., Wolfhart S., Chott A., Mutation in apoptosis genes: a pathogenetic factor for human disease, Mutation Res., 488:211-231,2001
60. Umansky R.S., Tomei L.D., Apoptosis in the heart, in: Kaufmann S.H. (ed.), Apoptosis. Pharmacological Implications and Therapeutic Opportunities, Advances in Pharmacol., Academic Press, vol. 41, pp. 383-405, 1997
61. Zerbst R., Antoni Gaudi, Benedikt Taschen Verlag Gmbh, pp. 197-232, 1993